CDAK News

Updated Monday, 11/9. The US IPO market remains relatively quiet following election week, with three biotechs and one SPAC scheduled to raise $340 million in the week ahead. Oncology biotech IN8bio (INAB) plans to raise $75 million at a $325 million market cap. IN8bio is focused on developing cancer therapies by employing allogeneic, autologous...read more

Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the breaks as we near the election, with just one new IPO filing. SPAC activity continued unabated however as nine submitted initial filings. The largest deal of the week, Array Technologies (ARRY) upsized and priced above the range to raise $1.0...read more

Codiak BioSciences, an early stage biotech developing novel exosome therapeutics for cancers, raised $83 million by offering 5.5 million shares at $15, the midpoint of the $14 to $16 range.  Codiak BioSciences plans to list on the Nasdaq under the symbol CDAK. Goldman Sachs, Evercore ISI, and William Blair acted as joint bookrunners on the deal. ...read more

Five biotechs, two medical device makers, a solar panel mounting manufacturer, and a Chinese retailer are scheduled to raise $2.0 billion in the week ahead. Several companies could join the IPO calendar early in the week, including leading cybersecurity brand McAfee (MCFE) and Vista-backed software maker Datto Holding (MSP), which are on...read more